Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta.

Singh KP, Singh MK, Gautam S.

Int J Exp Pathol. 2016 Apr;97(2):125-32. doi: 10.1111/iep.12176. Epub 2016 Jun 3.

PMID:
27256515
2.

Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation.

Ozcan G, Aykac E, Kasap Y, Nemutlu NT, Sen E, Aydinkarahaliloglu ND.

Drugs Real World Outcomes. 2016;3:33-43. Epub 2016 Jan 8.

3.

Deep Brain Stimulation during Pregnancy and Delivery: Experience from a Series of "DBS Babies".

Scelzo E, Mehrkens JH, Bötzel K, Krack P, Mendes A, Chabardès S, Polosan M, Seigneuret E, Moro E, Fraix V.

Front Neurol. 2015 Sep 1;6:191. doi: 10.3389/fneur.2015.00191. eCollection 2015.

4.

Mood stabilizers in pregnancy and lactation.

Grover S, Avasthi A.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S308-23. doi: 10.4103/0019-5545.161498. Review.

5.

Antipsychotics in pregnancy and lactation.

Babu GN, Desai G, Chandra PS.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S303-7. doi: 10.4103/0019-5545.161497. Review.

6.

Bipolar disorder in women.

Parial S.

Indian J Psychiatry. 2015 Jul;57(Suppl 2):S252-63. doi: 10.4103/0019-5545.161488. Review.

7.

Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy.

Sørensen MJ, Kjaersgaard MI, Pedersen HS, Vestergaard M, Christensen J, Olsen J, Parner E, Pedersen LH, Bech BH.

PLoS One. 2015 Jul 10;10(7):e0132280. doi: 10.1371/journal.pone.0132280. eCollection 2015.

8.

Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy.

Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH.

Obstet Gynecol. 2015 May;125(5):1224-35. doi: 10.1097/AOG.0000000000000759. Review.

9.

Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-Hoc Analysis.

Shao P, Ou J, Peng M, Zhao J, Chen J, Wu R.

PLoS One. 2015 Apr 24;10(4):e0123373. doi: 10.1371/journal.pone.0123373. eCollection 2015.

10.

Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Dec 24;7:7-29. doi: 10.2147/DHPS.S50556. eCollection 2015. Review.

11.

Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects.

Galbally M, Snellen M, Power J.

Ther Adv Drug Saf. 2014 Apr;5(2):100-9. doi: 10.1177/2042098614522682. Review.

12.

A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies.

Kulkarni J, Worsley R, Gilbert H, Gavrilidis E, Van Rheenen TE, Wang W, McCauley K, Fitzgerald P.

PLoS One. 2014 May 2;9(5):e94788. doi: 10.1371/journal.pone.0094788. eCollection 2014.

13.

Teratogenicity with olanzapine.

Prakash S, Chadda RK.

Indian J Psychol Med. 2014 Jan;36(1):91-3. doi: 10.4103/0253-7176.127266.

14.

Olanzapine use in a manic patient during second and third trimester pregnancy.

Choi L, Joo SH, Jeong JH.

Neuropsychiatr Dis Treat. 2014 Feb 17;10:325-8. doi: 10.2147/NDT.S59481. eCollection 2014.

15.

Prenatal antidepressant exposure: clinical and preclinical findings.

Bourke CH, Stowe ZN, Owens MJ.

Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014. Review.

16.

The use of psychotropic medication during pregnancy: how about the newborn?

Kieviet N, Dolman KM, Honig A.

Neuropsychiatr Dis Treat. 2013;9:1257-66. doi: 10.2147/NDT.S36394. Epub 2013 Aug 28. Review.

17.

Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report.

Rowe M, Gowda BA, Taylor D, Hannam S, Howard LM.

Ther Adv Psychopharmacol. 2012 Dec;2(6):265-8. doi: 10.1177/2045125312460395. No abstract available.

18.

Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance.

Brunner E, Falk DM, Jones M, Dey DK, Shatapathy CC.

BMC Pharmacol Toxicol. 2013 Aug 1;14:38. doi: 10.1186/2050-6511-14-38. Review.

19.

Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.

Sadowski A, Todorow M, Yazdani Brojeni P, Koren G, Nulman I.

BMJ Open. 2013 Jul 13;3(7). pii: e003062. doi: 10.1136/bmjopen-2013-003062. Print 2013.

20.

Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Toh S, Li Q, Cheetham TC, Cooper WO, Davis RL, Dublin S, Hammad TA, Li DK, Pawloski PA, Pinheiro SP, Raebel MA, Scott PE, Smith DH, Bobo WV, Lawrence JM, Dashevsky I, Haffenreffer K, Avalos LA, Andrade SE.

Arch Womens Ment Health. 2013 Apr;16(2):149-57. doi: 10.1007/s00737-013-0330-6. Epub 2013 Feb 7.

Items per page

Supplemental Content

Write to the Help Desk